Francisco J. Reynoso

Francisco J. Reynoso

Auto-generated profile, based on publicly available information

Francisco J. Reynoso

Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
NKNels C. Knutson
Nels C. Knutson
PSPamela P. Samson
Pamela P. Samson
GHGeoffrey D. Hugo
Geoffrey D. Hugo
SGS. Murty Goddu
S. Murty Goddu
FRFrancisco J. Reynoso
Francisco J. Reynoso
CRClifford G. Robinson
Clifford G. Robinson

1 July 2022 in Breast Cancer: Targets and Therapy
Verified
Journal Article
Open access
PDF file
HSHayley B Stowe
Hayley B Stowe
NANeal D Andruska
Neal D Andruska
FRFrancisco Reynoso
Francisco Reynoso
MTMaria Thomas
Maria Thomas
CBCarmen Bergom
Carmen Bergom
Adjuvant radiation therapy is a critical component of breast cancer management. However, when breast cancer patients receive incidental radiation to the heart, there is an increased risk of cardiac disease and mortality. This is most common for patients with left-sided breast cancers and those receiving nodal irradiation as part of treatment. The overall risk of cardiac toxicity increases 4– 16% with each Gray increase in mean heart radiation dose, with data suggesting that no lower limit exists which would eliminate cardiac risk entirely. Radiation techniques have improved over time, leading to lower cardiac radiation exposure than in the past. This decline is expected to reduce the incidence of radiation-induced heart dysfunction in patients. Deep inspiration breath hold (DIBH) is one such technique that was developed to reduce the risk of cardiac death and coronary events. DIBH is a non-invasive approach that capitalizes on the natural physiology of the respiratory cycle to increase the distance between the heart and the therapeutic target throughout the course of radiation therapy. DIBH has been shown to decrease the mean incidental radiation doses to the heart and left anterior descending coronary artery by approximately 20– 70%. In this review, we summarize different techniques for DIBH and discuss recent data on this technique.

1 May 2020 in Advances in Radiation Oncology
Verified
Journal Article
Open access
NKNels C. Knutson
Nels C. Knutson
WKWilliam R. Kennedy
William R. Kennedy
FRFrancisco J. Reynoso
Francisco J. Reynoso
JPJiayuan Peng
Jiayuan Peng
LHLauren E. Henke
Lauren E. Henke
BCBin Cai
Bin Cai
To test the feasibility of a simplified, robust, workflow for intracranial stereotactic radiation therapy (SRT) using a ring gantry linear accelerator (RGLA) equipped with a dual-layer stacked, staggered, and interdigitating multileaf collimator. Twenty recent clinical SRT cases treated using a radiosurgery c-arm linear accelerator were anonymized. From these data sets, a new planning workflow was developed and used to replan these cases, which then were compared to their clinical counterparts. Population-based dose-volume histograms were analyzed for target coverage and sparing of healthy brain. All plans underwent plan review and quality assurance and were delivered on an end-to-end verification phantom using image guidance to simulate treatment. The RGLA plans were able to meet departmental standards for target coverage and organ-at-risk sparing and showed plan quality similar to the clinical plans. RGLA plans showed increases in the 50% isodose in the axial plane but decreases in the sagittal and coronal planes. There were no statistically significant differences in the homogeneity index or number of monitor units between the 2 systems. There were statistically significant increases in conformity and gradient indices, with median values of 1.09 versus 1.11 and 2.82 versus 3.13, respectively, for the c-arm versus RGLA plans. These differences were not believed to be clinically significant because they met clinical goals. The population-based dose-volume histograms showed target coverage and organ-at-risk sparing similar to that of the clinical plans. All plans were able to meet the departmental quality assurance requirements and were delivered under image guidance on an end-to-end phantom with measurements agreeing within 3% of the expected value. RGLA plans showed a median reduction in delivery time of ≈50%. This work describes a simplified and efficient workflow that could reduce treatment times and expand access to SRT to centers using an RGLA.

10 September 2019 in Medical Physics
Verified
Journal Article
Closed access
PDF file
RLRuirui Liu
Ruirui Liu
TZTianyu Zhao
Tianyu Zhao
XZXiandong Zhao
Xiandong Zhao
FRFrancisco J. Reynoso
Francisco J. Reynoso

13 October 2025 in Journal of Physics D: Applied Physics
Verified
Journal Article
Open access
HGHamid Ghaznavi
Hamid Ghaznavi
MRMohammad Rezaee
Mohammad Rezaee
FRFrancisco Reynoso
Francisco Reynoso
ADArash Darafsheh
Arash Darafsheh
Radiation therapy (RT) employs ionizing radiation to kill cancerous cells. However, delivering radiation to tumors, typically embedded within normal tissues, inevitably exposes healthy organs to radiation, leading to collateral damage. This creates a tradeoff between the tumor control probability and normal tissue complication probability, ultimately limiting the dose that can be safely administered. While highly conformal RT techniques have improved tumor targeting and treatment efficacy, they remain inadequate for treating large and radioresistant tumors, pointing out the need for alternative strategies. Spatially fractionated RT, ultra-high dose rate RT, and nanoparticle-enhanced RT are emerging techniques with promise in enhancing tumor control while minimizing normal tissue toxicity. Successful clinical translation of these advanced techniques requires cross-disciplinary efforts aimed at technological innovation, a deeper understanding of the underlying radiobiological mechanisms, and the development of early-phase clinical trials. This paper provides an overview of these techniques and their associated challenges and opportunities.

5 November 2021 in Medical Physics
Verified
Journal Article
Closed access
PDF file
XZXiandong Zhao
Xiandong Zhao
RLRuirui Liu
Ruirui Liu
TZTianyu Zhao
Tianyu Zhao
FRFrancisco J. Reynoso
Francisco J. Reynoso